Cargando…
Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes
BACKGROUND: Glucocorticoid (GC) resistance is a major barrier in COPD treatment. We have shown increased expression of the drug efflux pump, Pgp1 in cytotoxic/pro-inflammatory lymphocytes in COPD. Loss of lymphocyte co-stimulatory molecule CD28 (lymphocyte senescence) was associated with a further i...
Autores principales: | Hodge, Greg, Jersmann, Hubertus, Tran, Hai B, Holmes, Mark, Reynolds, Paul N, Hodge, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301939/ https://www.ncbi.nlm.nih.gov/pubmed/25573300 http://dx.doi.org/10.1186/s12931-014-0161-7 |
Ejemplares similares
-
Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2015) -
Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2020) -
Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD
por: Hodge, Greg, et al.
Publicado: (2014) -
Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2016) -
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD
por: Hodge, Greg, et al.
Publicado: (2013)